Bruker Corporation
BRKR
$45.69
$0.711.58%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -15.74% | 13.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.74% | 13.56% | |||
| Cost of Revenue | -16.11% | 14.36% | |||
| Gross Profit | -15.34% | 12.70% | |||
| SG&A Expenses | -0.82% | 0.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -98.64% | 254.07% | |||
| Total Operating Expenses | -15.38% | 21.88% | |||
| Operating Income | -20.84% | -42.33% | |||
| Income Before Tax | -72.84% | 192.29% | |||
| Income Tax Expenses | -93.39% | 368.09% | |||
| Earnings from Continuing Operations | -46.23% | 149.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 59.38% | -190.91% | |||
| Net Income | -44.62% | 143.62% | |||
| EBIT | -20.84% | -42.33% | |||
| EBITDA | -10.78% | -26.79% | |||
| EPS Basic | -76.53% | 123.84% | |||
| Normalized Basic EPS | -7.98% | -53.25% | |||
| EPS Diluted | -79.59% | 123.84% | |||
| Normalized Diluted EPS | -7.96% | -53.42% | |||
| Average Basic Shares Outstanding | 0.13% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.13% | 0.46% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.91% | -- | |||